EFDID: 385615EFD: View Filing

Issuer: Reify Health, Inc. (0001570930) - D

Accession: 0001567619-21-014907 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001570930
  • Entity Name:
    Reify Health, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    33 Arch Street, 17th Floor
    Boston, MA, MA 02110
  • Persons:
    Related Persons 5
    Ralph J. Passarella
    Executive Officer, Director 
    Mr. Passarella is the Chief Executive Officer of the Issuer.
    Michael Lin
    Director, Executive Officer 
    Mr. Lin is the Secretary of the Issuer.
    David Fleshman
    Director
    Mark Fernandes
    Director
    Neeraj Agrawal
    Director
EDGAR: Offering Information
  • Accession Date:
    08/10/2021
  • First Sale Date:
    06/09/2021
  • Offering Amount:
    $220,000,053
  • Amount Sold:
    $220,000,053
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Series C Preferred Stock
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Reify Health, Inc./s/ Ralph PassarellaRalph PassarellaChief Executive Officer of the Issuer2021-08-10